News

ECTRIMS Congress

We are proud to announce our participation at ECTRIMS 2025 – the world’s leading congress dedicated to Multiple Sclerosis (MS).

As MS continues to affect millions of people worldwide, ECTRIMS offers a vital platform for researchers, clinicians, and healthcare professionals to exchange the latest insights, innovations, and breakthroughs in MS research, treatment, and care.

We look forward to connecting with global experts, sharing knowledge, and contributing to the advancement of MS care.

Latest News

A new chapter in our story.Salus has signed a share purchase agreement (SPA) for the acquisition of a 100 % stake in Farmedica, a specialist ...

We are proud to partner with Oncopeptides to expand access to Pepaxti® across Central and Eastern Europe. A targeted therapy for patients with multiple myeloma ...